Polycaprolactone spheres and theromosensitive pluronic F127 hydrogel for vocal fold augmentation: In vivo animal study for the treatment of unilateral vocal fold palsy

Laryngoscope

Volumn 123, Issue 7, 2013, Pages 1694-1703

  Kwon, Seong Keun ^a   Song, Jae Jun ^a   Cho, Chang Gun ^a   Park, Seok Won ^a   Choi, Soo Jung ^b   Oh, Se Heang ^c   Lee, Jin Ho ^b  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Hannam University   (South Korea)

^c Dankook University   (South Korea)

Author keywords

injection laryngoplasty; pluronic F127; polycaprolactone; Vocal fold palsy

Indexed keywords

HYDROXYAPATITE; POLOXAMER; POLOXAMER HYDROGEL; POLYCAPROLACTONE; POLYCAPROLACTONE SPHERE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAMERA; CONNECTIVE TISSUE; CONTROLLED STUDY; ELECTROKYMOGRAPHY; EXPERIMENTAL RABBIT; HISTOLOGY; IN VIVO STUDY; LARYNGOSCOPY; LARYNX SURGERY; MALE; NONHUMAN; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE; TISSUE GROWTH; UNILATERAL VOCAL CORD PARALYSIS; VIBRATION; VIDEOKYMOGRAPHY; VOCAL CORD PARALYSIS; VOCAL FOLD AUGMENTATION; VOCAL FOLD VIBRATION;

ANIMALS; DISEASE MODELS, ANIMAL; HYDROGEL; LARYNGOSCOPY; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PHONATION; POLYESTERS; PROSTHESES AND IMPLANTS; RABBITS; RECURRENT LARYNGEAL NERVE; VOCAL CORD PARALYSIS;

EID: 84879412308     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23879     Document Type: Article

References (20)

1. O'Leary MA, Grillone GA,. Injection laryngoplasty. Otolaryngol Clin North Am 2006; 39: 43-54. (Pubitemid 43199975)
2. Kwon TK, Buckmire R,. Injection laryngoplasty for management of unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 538-542. (Pubitemid 39565211)
3. Sun H, Mei L, Song C, Cui X, Wang P,. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials 2006; 27: 1735-1740. (Pubitemid 41759467)
4. Yang S, Leong KF, Du Z, Chua CK,. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng 2001; 7: 679-689. (Pubitemid 34042301)
5. Oh SH, Kim JK, Song KS, et al. Prevention of postsurgical tissue adhesion by anti-inflammatory drug-loaded pluronic mixtures with sol-gel transition behavior. J Biomed Mater Res A 2005; 72: 306-316. (Pubitemid 40271001)
6. Kim IG, Oh SH, Lee JY, Lee JH,. Bioactive porous beads as an injectable urethral bulking agent: in vivo animal study for the treatment of urinary incontinence. Tissue Eng Part A 2011; 17: 1527-1535.
7. Lim SM, Lee HJ, Oh SH, Kim JM, Lee JH,. Novel fabrication of PCL porous beads for use as an injectable cell carrier system. J Biomed Mater Res B Appl Biomater 2009; 90: 521-530.
8. Kim DY, Kim LS, Kim KH, et al. Videostrobokymographic analysis of benign vocal fold lesions. Acta Otolaryngol 2003; 123: 1102-1109. (Pubitemid 38021530)
9. Mikus JL, Koufman JA, Kilpatrick SE,. Fate of liposuctioned and purified autologous fat injections in the canine vocal fold. Laryngoscope 1995; 105: 17-22.
10. Defatta RA, Chowdhury FR, Sataloff RT,. Complications of injection laryngoplasty using calcium hydroxylapatite. J Voice 2011.
11. Mau T, Muhlestein J, Callahan S, Chan RW,. Modulating phonation through alteration of vocal fold medial surface contour. Laryngoscope 2012; 122: 2005-2014.
12. Senuma Y, Franceschin S, Hilborn JG, Tissieres P, Bisson I, Frey P,. Bioresorbable microspheres by spinning disk atomization as injectable cell carrier: from preparation to in vitro evaluation. Biomaterials 2000; 21: 1135-1144. (Pubitemid 30173152)
13. Oh SH, Kim IG, Lee JY, Lee JH,. Bioactive porous beads as an injectable urethral bulking agent: their in vitro evaluation on smooth muscle cell differentiation. Tissue Eng Part A 2011; 17: 655-664.
14. Yiou R, Lefaucheur JP, Atala A,. The regeneration process of the striated urethral sphincter involves activation of intrinsic satellite cells. Anat Embryol (Berl) 2003; 206: 429-435. (Pubitemid 36693763)
15. Cavazzana-Calvo M, Lagresle C, Hacein-Bey-Abina S, Fischer A,. Gene therapy for severe combined immunodeficiency. Annu Rev Med 2005; 56: 585-602. (Pubitemid 40299798)
16. Im GI, Kim HJ, Lee JH,. Chondrogenesis of adipose stem cells in a porous PLGA scaffold impregnated with plasmid DNA containing SOX trio (SOX-5,-6 and -9) genes. Biomaterials 2011; 32: 4385-4392.
17. Storrie H, Mooney DJ,. Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv Drug Deliv Rev 2006; 58: 500-514. (Pubitemid 43928169)
18. Jang JH, Houchin TL, Shea LD,. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices 2004; 1: 127-138. (Pubitemid 40220424)
19. De Laporte L, Shea LD,. Matrices and scaffolds for DNA delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59: 292-307. (Pubitemid 46879971)
20. Shea LD, Smiley E, Bonadio J, Mooney DJ,. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 1999; 17: 551-554. (Pubitemid 29262917)